Cancer screening unlikely to benefit patients with a short life expectancy: Less than 10 years and risks are likely to outweigh benefits

Breast and colorectal cancer screening should be targeted towards patients with a life expectancy greater than 10 years: for any shorter life expectancy the harms are likely to outweigh the benefits, concludes a new study.